RDN
0.007
75%
HMD
0.012
-36.8%
XAM
0.079
54.9%
ERA
0.002
-33.3%
NSX
0.033
50%
EIQ
0.24
-25%
ROG
0.005
25%
ICR
0.006
-25%
LDR
0.16
23.1%
MMR
0.003
-25%
MGA
0.061
22%
AZL
0.007
-22.2%
FRS
0.075
21%
ATX
0.051
-21.5%
OD6
0.03
20%
C1X
0.055
-21.4%
AM5
0.013
18.2%
TEM
0.004
-20%
BLU
0.007
16.7%
HCT
0.045
-19.6%
CLA
0.007
16.7%
ANR
0.005
-16.7%
CTQ
0.014
16.7%
AQX
0.005
-16.7%
HOR
0.021
16.7%
EMU
0.02
-16.7%
M24
0.014
16.7%
MEM
0.005
-16.7%
SPX
0.007
16.7%
RC1
0.005
-16.7%
OFX
1.315
16.4%
T92
0.025
-16.7%
OSX
0.015
15.4%
LTR
0.68
-16.6%
EXR
0.031
14.8%
ORD
0.39
-16.1%
EOS
1.48
14.7%
APX
1.23
-15.8%
AHF
0.047
14.6%
IVX
0.081
-14.7%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Imricor Medical Systems (ASX: IMR): Awarded CE mark approval

Developer of MRI-compatible devices, Imricor Medical Systems (ASX: IMR) has been awarded CE mark certification from the EU for its Vision-MR Diagnostic Catheter, allowing for manufacturing and release into the clinical market | ASX announcement: https://announcements.asx.com.au/asxpdf/20240306/pdf/0616gfxf12g8pc.pdf